Page last updated: 2024-11-06

trinexapac-ethyl

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Trinexapac-ethyl is a synthetic plant growth regulator that belongs to the triazole class of compounds. It is primarily used as a post-emergence herbicide to control the growth of grasses in various crops. Its mechanism of action involves inhibiting the biosynthesis of gibberellins, plant hormones that regulate stem elongation and leaf growth. This inhibition leads to a reduction in plant height, resulting in a more compact and sturdy plant structure. Trinexapac-ethyl is commonly used in cereal crops like wheat and barley to control the growth of grass weeds and promote tillering. It is also used in turfgrass management for controlling growth and enhancing the aesthetic appearance of lawns. Due to its effectiveness in reducing plant height and its relatively low toxicity, trinexapac-ethyl is an important tool for agricultural practices. Ongoing research focuses on understanding its effects on plant physiology, optimizing application rates, and developing novel formulations to improve its efficacy and environmental compatibility.'

trinexapac-ethyl: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

trinexapac-ethyl : An ethyl ester resulting from the formal condensation of the carboxy group of trinexapac with ethanol. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID92421
CHEMBL ID3182004
CHEBI ID81817
SCHEMBL ID118484
SCHEMBL ID10001994
MeSH IDM0455153

Synonyms (44)

Synonym
primo
cyclohexanecarboxylic acid, 4-(cyclopropylhydroxymethylene)-3,5-dioxo-, ethyl ester
cimectacarb
trinexapac-ethyl [iso]
epa pesticide chemical code 112602
moddus
4-(cyclopropyl-alpha-hydroxymethylene)-3,5-dioxocyclohexanecarboxylic acid ethyl ester
trinexapac-ethyl
ethyl 4-(cyclopropylhydroxymethylene)-3,5-dioxocyclohexanecarboxylate
ethyl 4-[cyclopropyl(hydroxy)methylidene]-3,5-dioxocyclohexane-1-carboxylate
95266-40-3
C18541
NCGC00255216-01
cas-95266-40-3
tox21_301906
dtxsid9032535 ,
dtxcid7012535
q89w563t9j ,
unii-q89w563t9j
AKOS016014448
ethyl 4-(cyclopropyl(hydroxy)methylene)-3,5-dioxocyclohexanecarboxylate
palisade
4-(cyclopropylhydroxymethylene)-3,5-dioxocyclohexanecarboxylic acid ethyl ester
trinexapac-ethyl [mi]
cga-163935
SCHEMBL118484
ethyl 4-[cyclopropyl(hydroxy)methylidene]-3,5-dioxocyclohexanecarboxylate
CHEBI:81817 ,
3-hydroxy-5-oxo-4-cyclopropanecarbonyl-cyclohex-3-ene-1-carboxylic acid ethyl ester
SCHEMBL10001994
RVKCCVTVZORVGD-QXMHVHEDSA-N
CHEMBL3182004
FT-0699262
trinexapac-ethyl, pestanal(r), analytical standard
cimectocarb-ethyl
DS-6168
Q27155616
mfcd01632318
cga 163935; cimectacarb; moddus; primo; primo maxx
C77286
VDA26640
ethyl 4-[cyclopropyl(hydroxy)methylene]-3,5-dioxocyclohexanecarboxylate
A902830
HY-W022973
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (4)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
acetylcholinesteraseHomo sapiens (human)Potency79.64070.002541.796015,848.9004AID1347395
AR proteinHomo sapiens (human)Potency54.94100.000221.22318,912.5098AID743036
estrogen nuclear receptor alphaHomo sapiens (human)Potency48.96620.000229.305416,493.5996AID743075
thyroid stimulating hormone receptorHomo sapiens (human)Potency2.73060.001628.015177.1139AID1224843
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (36.36)29.6817
2010's4 (36.36)24.3611
2020's3 (27.27)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 33.44

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index33.44 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index4.69 (4.65)
Search Engine Demand Index70.61 (26.88)
Search Engine Supply Index3.50 (0.95)

This Compound (33.44)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]